Keyphrases
Enhanced Recovery after Surgery (ERAS®)
71%
Advanced Ovarian Cancer
71%
Ovarian Cystectomy
54%
Ovarian Cancer
50%
Presentation Management
47%
Clinical Presentation
47%
Clinical Management
47%
Clinical Outcomes
47%
High-grade Serous Ovarian Cancer (HGSOC)
47%
Advanced Stage
29%
Cost Analysis
29%
Stage IIIC
27%
HIV Infection
27%
Prospective Randomized Trial
27%
Hospital Costs
27%
Ovarian Cancer Patients
27%
Progression-free Survival
26%
Endometrial Adenocarcinoma
23%
Long-term Oncological Outcomes
23%
Transitional Cell Carcinoma
23%
Nerve-sparing Radical Hysterectomy
23%
Nerve Sparing
23%
Vulvar Intraepithelial Neoplasia
23%
Epithelial Ovarian Cancer
23%
Aortic Lymphadenectomy
23%
Vaginal Intraepithelial Neoplasia (VaIN)
23%
STELLA
23%
Extraperitoneal
23%
Tubal Cancer
23%
Interval Debulking Surgery
23%
Peritoneal Cancer
23%
Primary Debulking Surgery
23%
Streptococcal Meningitis
23%
Outside-in
23%
Cervical Pregnancy
23%
Uterine Angioleiomyoma
23%
Surgical Staging
23%
Prognostic Marker
23%
Systematic Literature Review
23%
Inside-out
23%
Resectability
23%
Rare Presentation
23%
Cancer Patients
23%
Angiomyolipoma
23%
Infection Rate
23%
Laparoscopy
23%
Definitive Diagnosis
23%
Group B Streptococcus
23%
Transobturator Tape
23%
Endometrial Cancer
23%
Medicine and Dentistry
Ovarian Cancer
100%
Enhanced Recovery After Surgery
61%
Ovarian Cancer Surgery
53%
Human Immunodeficiency Virus
47%
Health Care Cost
47%
Laparoscopic Surgery
33%
Krukenberg Tumor
28%
Retroperitoneal Lymph Node Dissection
27%
Cost Benefit Analysis
27%
Human Immunodeficiency Virus Infection
26%
Cytoreductive Surgery
26%
Metastatic Carcinoma
23%
Cervical Pregnancy
23%
Group B Streptococcal Meningitis
23%
Transitional Cell Carcinoma
23%
Angioleiomyoma
23%
Radical Hysterectomy
23%
Vaginal Intraepithelial Neoplasia
23%
microRNA
23%
Vulvar Intraepithelial Neoplasia
23%
Endometrium
23%
Systematic Review
23%
Debulking Surgery
23%
Peritoneum Cancer
23%
Intestine Preparation
23%
Hospital Cost
23%
Uterine Cancer
23%
Patient Care
23%
Serous Carcinoma
23%
Diseases
22%
Endometrium Carcinoma
21%
Progression Free Survival
18%
Drug Resistance
14%
Biological Marker
11%
Group B Streptococcal Infection
11%
Recurrence Free Survival
11%
Neoplasm
9%
Robot Assisted Laparoscopy
9%
Intensive Care Unit
9%
Neoadjuvant Chemotherapy
8%
Overall Survival
8%
Proteomics
7%
Cell Differentiation
6%
Infection
6%
Hysterectomy
6%
Immunohistochemistry
6%
Bleeding
6%
Operation Duration
6%
Cohort Study
6%
Univariate Analysis
5%